Abiopharma

Wolf Haldenstein Adler Freeman & Herz LLP is investigating potential securities fraud claims on behalf of the shareholders of Sleep Number Corporation (NASDAQ: SNBR)

United Community Banks, Inc. Announces Agreement to Sell Equipment Finance Business, Consisting of Navitas Credit Corp. and NLFC Reinsurance Corp., to Funds Managed by Wafra Inc.

CervoMed to Participate in the H.C. Wainwright 7th Annual Neuro Perspectives Expert Summit

Exodus Launches Exodus Markets for Tokenized Assets with Ondo Finance

Sharon AI Announces Six Year Strategic Compute Collaboration with NVIDIA

Fervo Energy to Report First Quarter 2026 Results on June 22, 2026

OTC Markets Group Welcomes Tesoro Gold Ltd to OTCQX

MBX Biosciences Announces One-Year Data Demonstrating Sustained Benefit of Once-Weekly Canvuparatide as a Potential PTH Replacement Therapy in Chronic Hypoparathyroidism

Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million

Kymera Therapeutics Presents Phase 1 Data in Healthy Japanese Adults for KT-621, a First-in-Class Oral STAT6 Degrader, at the Japanese Dermatological Association Annual Meeting